Viridian Therapeutics Inc (VRDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 212,382 | 99,594 | 102,827 | 155,579 | 42,299 |
| Marketable Securities | 662,270 | 617,990 | 374,543 | 268,971 | 154,666 |
| Other current assets | 0 | 0 | 102 | 102 | 451 |
| TOTAL | $894,233 | $738,461 | $486,478 | $431,173 | $200,163 |
| Non-Current Assets | |||||
| PPE Net | 1,228 | 1,236 | 1,672 | 1,326 | 375 |
| Other Non-Current Assets | 3,957 | 2,706 | 2,274 | 2,592 | 3,171 |
| TOTAL | $5,185 | $3,942 | $3,946 | $3,918 | $3,546 |
| Total Assets | $899,418 | $742,403 | $490,424 | $435,091 | $203,709 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,683 | 2,143 | 2,239 | 14,234 | 2,329 |
| Accrued Expenses | 62,013 | 45,731 | 24,108 | 18,827 | 11,018 |
| TOTAL | $70,696 | $47,874 | $26,635 | $33,349 | $13,636 |
| Non-Current Liabilities | |||||
| Long Term Debt | 49,940 | 20,582 | 20,205 | 4,645 | N/A |
| Deferred Revenues | N/A | N/A | 288 | 288 | 289 |
| Other Non-Current Liabilities | 56,615 | 2,308 | 989 | 1,172 | 1,208 |
| TOTAL | $106,555 | $22,890 | $21,767 | $6,678 | $2,357 |
| Total Liabilities | $177,251 | $70,764 | $48,402 | $40,027 | $15,993 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 102,207 | 81,485 | 62,768 | 42,898 | 25,913 |
| Common Shares | 1,018 | 810 | 540 | 414 | 239 |
| Retained earnings | -1,338,458 | -995,857 | -725,908 | -488,174 | -358,300 |
| Other shareholders' equity | 132,503 | 188,875 | 206,854 | 141,757 | 133,676 |
| TOTAL | $722,167 | $671,639 | $442,022 | $395,064 | $187,716 |
| Total Liabilities And Equity | $899,418 | $742,403 | $490,424 | $435,091 | $203,709 |